EQUITY RESEARCH MEMO

Clear Guide Medical

Generated 5/4/2026

Executive Summary

Conviction (model self-assessment)60/100

Clear Guide Medical is a Baltimore-based medical device company specializing in advanced needle guidance systems for interventional procedures. Founded in 2012, the company has developed a platform that integrates ultrasound and electromagnetic tracking to provide real-time, 3D guidance for biopsies and other needle-based interventions. According to the company, their system has demonstrated performance comparable to established competitors like Philips PercuNav in lab, veterinary, and clinical settings. The technology aims to improve accuracy, reduce procedure time, and minimize complications, addressing a significant need in minimally invasive diagnostics and therapeutics. As a private company with limited public disclosures, Clear Guide Medical appears to be in a growth phase, potentially seeking regulatory approvals or partnerships to scale commercial adoption. The digital health and medical device sectors continue to see strong demand for precision guidance solutions, positioning the company favorably in a competitive landscape that values improved patient outcomes and procedural efficiency.

Upcoming Catalysts (preview)

  • Q3 2026FDA 510(k) clearance for next-generation guidance platform70% success
  • Q4 2026Strategic partnership with a major imaging OEM50% success
  • Q1 2027Publication of pivotal clinical trial results in a peer-reviewed journal60% success
Locked sections
  • · Pipeline Analysis
  • · Competitive Landscape
  • · Catalyst Calendar (full 12-month)
  • · Bull Case
  • · Bear Case
  • · Counterfactual Scenarios
  • · Valuation Notes
  • · SEC Filing Highlights
  • · Insider Activity
  • · Literature Watch
  • · Patent Landscape
  • · Mechanism Cluster Map
  • · Audio Briefing (5 min)